CytoAstra

🗓 Founded 2016👥 4 employees💰 Last funded Jun 2026
Biotechnology Research🌐 cytoastra.com
Website LinkedIn
CytoAstra has developed the Cytophone, which uses a non-invasive technology called In Vivo Photoacoustic Flow Cytometry. The Cytophone technology uses a transcutaneous laser that detects abnormal or infected cells in the veins of a patient’s hands at a depth of a few millimeters. The laser, pain free to the patient, detects highly-localized light-absorbing contrast agents identifying the diseased or infected cells.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CytoAstra?
CytoAstra has 1 investors on record on gritt.io and 1 late-stage investors.
When did CytoAstra last raise funding?
The most recent investment in CytoAstra recorded on gritt.io was in June 2026.
When was CytoAstra founded?
CytoAstra was founded in 2016.
What industry is CytoAstra in?
CytoAstra operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.